Remi Palmier
Dijon, 21000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Factors Influencing the Duration of Maintenance Therapy in Metastatic Colorectal Cancer.
Journal: Cancers
Published: October 17, 2024
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Journal: Frontiers in oncology
Published: September 13, 2023
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 16, 2021
A colonoscopy quality improvement intervention in an endoscopy unit.
Journal: Scientific reports
Published: June 11, 2021
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2021
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 30, 2020
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX.
Journal: Anticancer research
Published: May 25, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026